Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Coherus Oncology, Inc. (CHRS) Institutional Ownership & Insider Trading

147 institutions reported holding Coherus Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CHRSCoherus Oncology, Inc.Follow CHRS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
156.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

147 institutions held 45.5% of the shares. Across filers that reported both quarters, shares held changed -3.2%.

Increased+60New+8Decreased-37Closed-16

Largest moves, shares (millions)

BlackRock+1.6MGeode Capital Management+0.6MVanguard Capital Management+0.5MTang Capital Management-1.9MPropel Bio Management-1.4MAlyeska Investment Group-0.5M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-5.9Sep 24-11.4Dec 24-3.5Mar 25-6.7Jun 25-3.9Sep 25+0.9Dec 25+9.6Mar 26-1.9Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2614770-3.2%6083716
Mar 2615659+23.3%4632369
Dec 2512451+2.0%3321279
Sep 2510952-7.0%31163016
Jun 2511055-10.8%32143218
Mar 2511662-5.3%39112516
Dec 2412165-14.9%30263234
Sep 2412877-8.3%38133019

Coherus Oncology, Inc. — questions

Who owns Coherus Oncology, Inc. stock?
147 institutions reported Coherus Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Timothy G. Youngquist 2020 Irrevocable Trust (8.4%), BlackRock, Inc. (7.8%), VANGUARD CAPITAL MANAGEMENT LLC (3.9%).

Every figure on this page comes from Coherus Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.